An Emerging Approval Trend At FDA: More First-Time Sponsors

There is a surprising trend in the list of FDA approvals in 2011: an increase in the number of small biopharma companies opting to forgo Big Pharma partnerships and submit new product applications on their own. Here’s how these “emerging sponsors” are changing the way FDA does business—for big and small companies alike.

More from Approval Standards

More from Pathways & Standards